Published in Prostaglandins on November 01, 1979
Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat. Br J Pharmacol (1981) 1.24
Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br J Pharmacol (1984) 1.21
The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat. Br J Pharmacol (1983) 1.18
The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol (1981) 1.13
Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol (2005) 0.99
Effects of prostaglandin E2, propranolol and nitroglycerine with halothane, pethidine or pentobarbitone anaesthesia on arrhythmias and other responses to ligation of a coronary artery in rats. Br J Pharmacol (1983) 0.96
Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br J Pharmacol (1983) 0.90
Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat. Br J Pharmacol (1983) 0.83
Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. Br J Pharmacol (1993) 0.82
Proceedings of the British Pharmacological Society. 5th-7th January, 1983. Abstracts. Br J Pharmacol (1983) 0.75
The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias. Br J Pharmacol (1989) 0.75
Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts. Basic Res Cardiol (1981) 0.75
The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. Br J Pharmacol (1982) 0.75
Wither, whether and whither pharmacology. Trends Pharmacol Sci (1994) 11.52
Suppression of the synthesis of cellular macromolecules by herpes simplex virus. J Gen Virol (1978) 3.57
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res (1988) 2.12
Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl Environ Microbiol (1997) 1.73
On the association of virus proteins with the nuclei of cells infected with herpes simplex virus. J Gen Virol (1978) 1.66
Invertebrate responses to the management of genetically modified herbicide-tolerant and conventional spring crops. II. Within-field epigeal and aerial arthropods. Philos Trans R Soc Lond B Biol Sci (2003) 1.58
Invertebrate responses to the management of genetically modified herbicide-tolerant and conventional spring crops. I. Soil-surface-active invertebrates. Philos Trans R Soc Lond B Biol Sci (2003) 1.57
Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol (1986) 1.52
Cardiac transplantation does not effect ischaemia-induced arrhythmias in rats. Cardiovasc Res (1999) 1.48
Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol (1983) 1.36
Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol (1987) 1.34
The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol Rev (2001) 1.31
Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae. Microbiology (1998) 1.25
M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate. FASEB J (2008) 1.25
Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br J Pharmacol (1984) 1.21
Association of HSV-1 with cervical infection. Lancet (1981) 1.20
The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat. Br J Pharmacol (1983) 1.18
The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type. J Clin Microbiol (2001) 1.16
A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infect Immun (1998) 1.11
An improved perfusion apparatus for small animal hearts. J Pharmacol Methods (1986) 1.07
Steroid receptors in human lung cancer cytosols. Cancer Lett (1982) 1.06
Expression and purification of recombinant human indoleamine 2, 3-dioxygenase. Protein Expr Purif (2000) 1.06
The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat. Br J Pharmacol (1985) 1.04
Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg (2001) 1.04
Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer. Cancer (2000) 1.02
Molecular analysis of the bvg-repressed urease of Bordetella bronchiseptica. Microb Pathog (1996) 1.02
Temperature dependent expression of an acid phosphatase by Bordetella bronchiseptica: role in intracellular survival. Microb Pathog (1997) 1.02
The timing of autologous latissimus dorsi breast reconstruction and effect of radiotherapy on outcome. J Plast Reconstr Aesthet Surg (2008) 1.01
Lipopolysaccharide O-antigen biosynthesis in Shigella dysenteriae serotype 1: analysis of the plasmid-carried rfp determinant. Microb Pathog (1994) 1.01
Effects of halothane anesthesia compared with fentanyl anesthesia and no anesthesia during coronary ligation in rats. Anesthesiology (1983) 1.00
Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. J Pharmacol Toxicol Methods (1994) 1.00
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Br J Cancer (2011) 0.99
Use of a sentinel system for field measurements of Cryptosporidium parvum oocyst inactivation in soil and animal waste. Appl Environ Microbiol (1999) 0.99
Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun (2000) 0.99
The regional treatment of liver metastases from breast cancer. J Surg Oncol (1994) 0.98
Incidence of estrogen receptor in benign nevi and human malignant melanoma. JAMA (1980) 0.98
Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade. J Pharmacol Exp Ther (1989) 0.97
Phosphorylation of a ribosomal protein and of virus-specific proteins in cells infected with herpes simplex virus. J Gen Virol (1979) 0.96
The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat. Br J Pharmacol (1986) 0.96
Soft tissue sarcomas of the adult head and neck. Cancer (1985) 0.96
Effects of prostaglandin E2, propranolol and nitroglycerine with halothane, pethidine or pentobarbitone anaesthesia on arrhythmias and other responses to ligation of a coronary artery in rats. Br J Pharmacol (1983) 0.96
Thyroid hormone insufficiency during brain development reduces parvalbumin immunoreactivity and inhibitory function in the hippocampus. Endocrinology (2006) 0.95
Streptococcus pyogenes prtFII, but not sfbI, sfbII or fbp54, is represented more frequently among invasive-disease isolates of tropical Australia. Epidemiol Infect (2002) 0.94
The mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9. Br J Pharmacol (1988) 0.94
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker. Br J Pharmacol (1991) 0.94
Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg (1999) 0.94
Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections. J Clin Pathol (2002) 0.93
Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Cardiovasc Res (1993) 0.93
Characterisation of the urease gene cluster in Bordetella bronchiseptica. Gene (1998) 0.92
Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin. Cancer Res (1980) 0.91
Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br J Pharmacol (1983) 0.90
Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis. Infect Immun (1991) 0.90
Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats. Br J Pharmacol (1986) 0.90
Effects of glucocorticoids on the growth of human fibrosarcoma cell line HT-1080. Cancer Res (1986) 0.88
Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA. Infect Immun (1991) 0.87
Arrhythmias associated with myocardial ischaemia and infarction. Mol Aspects Med (1985) 0.87
Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group study. J Immunother (1998) 0.87
Two distinct genotypes of prtF2, encoding a fibronectin binding protein, and evolution of the gene family in Streptococcus pyogenes. J Bacteriol (2004) 0.87
Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Br J Pharmacol (1992) 0.87
Food allergy: gambling your life on a take-away meal. Int J Environ Health Res (2005) 0.87
Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion. Eur J Pharmacol (1992) 0.87
Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias. J Mol Cell Cardiol (1998) 0.86
A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits. J Pharmacol Toxicol Methods (1997) 0.86
Construction of a transposon containing a gene for polygalacturonate trans-eliminase from Klebsiella oxytoca. Arch Microbiol (1987) 0.86
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study. J Clin Oncol (1998) 0.86
Pelvic exenteration. J Surg Oncol (1985) 0.85
Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat. Proc West Pharmacol Soc (1990) 0.85
A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers. Cell Death Dis (2013) 0.85
Massive subcutaneous emphysema: an unusual presentation of jejunal perforation. Am Surg (1981) 0.85
Selective analysis of the sentinel node in breast cancer. Am J Surg (2001) 0.85
Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation. J Pharmacol Exp Ther (1986) 0.85
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H. Eur J Pharmacol (1994) 0.85
Investigation of the validity and reliability of four objective techniques for measuring forward shoulder posture. J Orthop Sports Phys Ther (1997) 0.85
Delayed appearance of propranolol sensitivity in cultured heart cells. Eur J Pharmacol (1977) 0.84
Effects of calcium antagonists on mean circulatory filling pressure in the conscious rat. J Cardiovasc Pharmacol (1988) 0.84
Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits. Vaccine (1998) 0.84
The actions of felodipine on arrhythmias and other responses to myocardial ischaemia in conscious rats. Eur J Pharmacol (1985) 0.84
The action of prostaglandin E2 and F1alpha on myocardial ischaemia-infarction arrhythmias in the dog. Prostaglandins (1978) 0.84
Mexiletine's antifibrillatory actions are limited by the occurrence of convulsions in conscious animals. Eur J Pharmacol (1992) 0.84
Effects of (-), (+/- ), and (+) verapamil on coronary occlusion-induced mortality and infarct size. J Cardiovasc Pharmacol (1987) 0.84
Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF). Infect Immun (1997) 0.84
Dose and image quality comparison between prospectively gated axial and retrospectively gated helical coronary CT angiography. Br J Radiol (2011) 0.84
Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. Cancer Invest (1996) 0.83
Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microb Pathog (2001) 0.83
Estrogen receptor in malignant melanoma. J Clin Oncol (1987) 0.83
Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia. Infect Immun (1996) 0.83
Distribution of steroid hormone receptors in human soft tissue sarcomas. Surgery (1981) 0.83
Cutaneous thick melanoma. Prognosis and treatment. Arch Surg (1987) 0.82
Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis. Lett Appl Microbiol (2002) 0.82
Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. Br J Pharmacol (1993) 0.82
Regulation of indoleamine 2,3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens. Relevance for senile nuclear cataract. Adv Exp Med Biol (1999) 0.81
Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats. Br J Pharmacol (1989) 0.81
A novel Escherichia coli expression-export vector containing alkaline phosphatase as an insertional inactivation screening system. Gene (1994) 0.81